Literature DB >> 12000618

Clinical significance of the emergence of bacterial resistance in the hospital environment.

I K Hosein1, D W Hill, L E Jenkins, J T Magee.   

Abstract

Antibiotic resistance is an increasing threat in hospitals and both morbidity and mortality from infections are greater when caused by drug-resistant organisms. Whilst hospitals are universally blamed for this increase, there is an insufficient appreciation of external sources of resistance, such as when patients are admitted to hospitals from long-term care facilities in the community. The use of antibiotics in family practice and animal husbandry has also been linked to drug resistance being encountered in the hospital setting. Justifiable hospital antibiotic use, which can be life saving, may lead to 'collateral damage' with the emergence of resistance in non-target bacteria in the bowel, for example, with subsequent spread by cross-infection. At a management level, antibiotic resistance can have a significant impact on the ability of hospitals to maintain services since cohorting of patients and ward closures from outbreaks add to continuing bed shortages and waiting lists. Hospital laboratories must review their standard operating procedures since some resistance mechanisms may be missed by current methods of antibiotic susceptibility testing. With increasing public concern from press reports of 'multiresistant Staphylococcus aureus killer virus' and other drug-resistant organisms, there will inevitably be a push by national authorities for more surveillance data on antibiotic resistance; however, the cost-effectiveness of different surveillance strategies should be considered. Clinical governance and risk management are dominant themes in the National Health Service and hospital hygiene and antibiotic resistance are likely to feature prominently in audits related to these themes in the near future.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12000618

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  6 in total

1.  Horizontal transfer of erythromycin resistance from Clostridium difficile to Butyrivibrio fibrisolvens.

Authors:  Patrizia Spigaglia; Fabrizio Barbanti; Paola Mastrantonio
Journal:  Antimicrob Agents Chemother       Date:  2005-12       Impact factor: 5.191

2.  Novel approach to mapping of resistance mutations in whole genomes by using restriction enzyme modulation of transformation efficiency.

Authors:  Claude G Lerner; Stephan J Kakavas; Christian Wagner; Richard T Chang; Philip J Merta; Xiaoan Ruan; Randy E Metzger; Bruce A Beutel
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  The Integration of Proteomics and Metabolomics Data Paving the Way for a Better Understanding of the Mechanisms Underlying Microbial Acquired Drug Resistance.

Authors:  Suereta Fortuin; Nelson C Soares
Journal:  Front Med (Lausanne)       Date:  2022-05-06

4.  Risk factors for infection with pathogenic and antimicrobial-resistant fecal bacteria in northern elephant seals in California.

Authors:  Robyn A Stoddard; Edward R Atwill; Frances M D Gulland; Melissa A Miller; Haydee A Dabritz; Dave M Paradies; Karen R Worcester; Spencer Jang; Judy Lawrence; Barbara A Byrne; Patricia A Conrad
Journal:  Public Health Rep       Date:  2008 May-Jun       Impact factor: 2.792

5.  Global Health Solidarity.

Authors:  Peter G N West-Oram; Alena Buyx
Journal:  Public Health Ethics       Date:  2016-05-06       Impact factor: 1.940

6.  Antibiotic susceptibility of wound swab isolates in a tertiary hospital in Southwest Nigeria.

Authors:  Eguono Erhinyaye Omoyibo; Ayodeji Olarewaju Oladele; Muhammad Habib Ibrahim; Oluwakayode Temitope Adekunle
Journal:  Ann Afr Med       Date:  2018 Jul-Sep
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.